GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Medeze Group PCL (BKK:MEDEZE) » Definitions » Current Deferred Revenue

Medeze Group PCL (BKK:MEDEZE) Current Deferred Revenue : ฿43.1 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Medeze Group PCL Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Medeze Group PCL's current deferred revenue for the quarter that ended in Mar. 2024 was ฿43.1 Mil.

Medeze Group PCL Current Deferred Revenue Historical Data

The historical data trend for Medeze Group PCL's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medeze Group PCL Current Deferred Revenue Chart

Medeze Group PCL Annual Data
Trend
Current Deferred Revenue

Medeze Group PCL Semi-Annual Data
Mar23 Mar24
Current Deferred Revenue - 43.09

Medeze Group PCL Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Medeze Group PCL's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Medeze Group PCL Business Description

Traded in Other Exchanges
N/A
Address
Phutthamonthon Sai 4 Road, 28/9 Moo 8, Krathum Lom, Sam Phran, Nakhon Pathom, THA, 73220
Medeze Group PCL is engaged in the business of providing stem cell storage, analyzing, isolation, cultivation, and preservation services for medical use. It is organised into four reportable segments: Stem cell sample collection service segment; White blood cell potential testing service segment; Other services segment and Sales of products segment.

Medeze Group PCL Headlines

No Headlines